72 results
Page 2 of 4
S-3ASR
EX-4.4
ftmrcb68tl
17 Dec 21
Automatic shelf registration
12:00am
S-3ASR
EX-4.3
6k186desudnfvshf0hi
17 Dec 21
Automatic shelf registration
12:00am
S-3ASR
ke68qg
17 Dec 21
Automatic shelf registration
12:00am
8-K
EX-99.1
asii5
1 Dec 21
Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD
7:00am
8-K
EX-99.1
0vqipxe7 4ipv
12 Apr 21
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
7:17am
8-K
EX-99.1
wf3r0rne2h
18 Mar 21
Sage Therapeutics Announces Continued Positive Zuranolone Data for Both
6:55am
8-K
EX-99.1
e7jzd 3nk1jdhub
15 Oct 20
Sage Therapeutics Announces Positive Interim, Topline Zuranolone
9:14am